Vitamin D Supplementation Could Potentially Reduce Risk of COVID-19
Infections and Deaths
- Jing Qin Tay,
- Ajay L Mahajan,
- M Julie Thornton
Abstract
Vitamin D has long been known to be a major regulator for both the
endocrine and the immune system. With the advent of COVID-19 pandemic,
there has been a growing interest in looking at the feasibility of using
vitamin D as a preventative and therapeutic option in the management of
the disease. A low serum level of vitamin D is linked to higher
incidence of respiratory tract infection and disease progression.
Vitamin D supplementation has proven to be effective in enhancing the
immune system, strengthen lung epithelial barrier, and prevention of
unchecked inflammatory response. Previous studies on the roles of
vitamin D in managing influenza and other enveloped virus infection
could shed light on the possible roles of vitamin D in the current
pandemic. More randomised controlled trials are needed to explore the
effects of vitamin D supplementation on COVID-19 infection.17 May 2020Submitted to International Journal of Clinical Practice 18 May 2020Submission Checks Completed
18 May 2020Assigned to Editor
26 May 2020Reviewer(s) Assigned
21 Oct 2020Review(s) Completed, Editorial Evaluation Pending